Cargando…
Decreased expression of farnesoid X receptor may indicate poor prognosis in patients with colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is one of the most common malignancies worldwide. Many studies showed that increased secretion of bile acid may contribute to the pathogenesis of CRC. Farnesoid X receptor (FXR) plays an important role in several physiological functions of bile acid metabolism and...
Autores principales: | Zhang, Danying, Weng, Shuqiang, Cui, Can, Dong, Ling, Shen, Xizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797427/ https://www.ncbi.nlm.nih.gov/pubmed/35117795 http://dx.doi.org/10.21037/tcr-19-2723 |
Ejemplares similares
-
Comprehensive Investigation Illustrates the Role of M2 Macrophages and Its Related Genes in Pancreatic Cancer
por: Zhang, Danying, et al.
Publicado: (2023) -
Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer
por: Hu, Tingting, et al.
Publicado: (2015) -
The Farnesoid X Receptor: Good for BAD
por: Keely, Stephen J., et al.
Publicado: (2016) -
Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
por: Yu, Junhui, et al.
Publicado: (2020) -
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010)